| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.032 | 0.6 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.1 | 0.6 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |